Please ensure Javascript is enabled for purposes of website accessibility
Idera Pharmaceuticals Stock Quote

Idera Pharmaceuticals (NASDAQ: IDRA)

$2.28
(0.7%)
$0.02
Price as of March 27, 2023, 3:59 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Idera Pharmaceuticals Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
IDRA
S&P 0%

Idera Pharmaceuticals Company Info

The Company is engaged in the discovery and development of synthetic DNA and RNA-based compounds for the treatment of cancer, infectious diseases, autoimmune diseases, and asthma/allergies, and for use as vaccine adjuvants.

News & Analysis

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
395%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/27/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.